High-dose sirnas upregulate mouse Eri-1 at both transcription and posttranscription levels

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Bian, Yingnan ^a   Zhou, Wei ^a   Zhao, Yingchun ^a   Li, Xiaoping ^a   Geng, Wei ^a   Hao, Ruixin ^a   Yang, Qing ^a   Huang, Weida ^a,b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI ADVANCED RESEARCH INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MESSENGER RNA; SMALL INTERFERING RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR SP1; ERI1 PROTEIN, MOUSE; EXONUCLEASE; PRIMER DNA; STAT3 PROTEIN, MOUSE;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONTROLLED STUDY; DNA BINDING MOTIF; EMBRYO; ERI 1 GENE; ETS 1 GENE; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; POSTTRANSCRIPTIONAL GENE SILENCING; PROMOTER REGION; PROTEIN PROCESSING; REPORTER GENE; RNA INTERFERENCE; SP1 GENE; STAT3 GENE; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; CHO CELL; CHROMATIN IMMUNOPRECIPITATION; CRICETULUS; GEL MOBILITY SHIFT ASSAY; GENETICS; HAMSTER; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROCESSING; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CHO CELLS; CHROMATIN IMMUNOPRECIPITATION; CRICETINAE; CRICETULUS; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EXONUCLEASES; MICE; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 80054791942     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026466     Document Type: Article

References (95)

1. Sioud M, Furset G, (2006) Molecular basis for the immunostimulatory potency of small interfering RNAs. Journal of Biomedicine and Biotechnology 2: 4.
2. Pushparaj PN, Aarthi JJ, Manikandan J, Kumar SD, (2008) siRNA, miRNA, and shRNA: in vivo Applications. Journal of Dental Research 87: 992.
3. Meister G, Tuschl T, (2004) Mechanisms of gene silencing by double-stranded RNA. Nature 431: 343-349.
4. Zheng ZM, Tang S, Tao M, (2005) Development of resistance to RNAi in mammalian cells. Annals of the New York Academy of Sciences 1058: 105.
5. Filipowicz W, Jaskiewicz L, Kolb FA, Pillai RS, (2005) Post-transcriptional gene silencing by siRNAs and miRNAs. Current opinion in structural biology 15: 331-341.
6. Burgyán J, (2008) Role of silencing suppressor proteins. METHODS IN MOLECULAR BIOLOGY-CLIFTON THEN TOTOWA- 451: 69.
7. Kennedy S, Wang D, Ruvkun G, (2004) A conserved siRNA-degrading RNase negatively regulates RNA interference in C. elegans. Nature 427: 645-649.
8. Fischer S, Butler MD, Pan Q, Ruvkun G, (2008) Trans-splicing in C. elegans generates the negative RNAi regulator ERI-6/7. Nature 455: 491-496.
9. Duchaine TF, Wohlschlegel JA, Kennedy S, Bei Y, Conte D, et al. (2006) Functional proteomics reveals the biochemical niche of C. elegans DCR-1 in multiple small-RNA-mediated pathways. Cell 124: 343-354.
10. Hong J, Qian Z, Shen S, Min T, Tan C, et al. (2005) High doses of siRNAs induce eri-1 and adar-1 gene expression and reduce the efficiency of RNA interference in the mouse. Biochemical Journal 390: 675.
11. Hong J, Zhao Y, Li Z, Huang W, (2007) esiRNA to eri-1 and adar-1 genes improving high doses of c-myc-directed esiRNA effect on mouse melanoma growth inhibition. Biochemical and Biophysical Research Communications 361: 373-378.
12. Ryu H, Lee J, Olofsson BA, Mwidau A, Deodoglu A, et al. (2003) Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proceedings of the National Academy of Sciences of the United States of America 100: 4281.
13. Bouwman P, Philipsen S, (2002) Regulation of the activity of Sp1-related transcription factors. Molecular and cellular endocrinology 195: 27-38.
14. Kamemura K, Hart GW, (2003) Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription. Progress in nucleic acid research and molecular biology 73: 107-136.
15. Waby JS, Chirakkal H, Yu C, Griffiths GJ, Benson RS, et al. (2010) Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line. Mol Cancer 9: 275.
16. Leggett RW, Armstrong SA, Barry D, Mueller CR, (1995) Sp1 is phosphorylated and its DNA binding activity down-regulated upon terminal differentiation of the liver. Journal of Biological Chemistry 270: 25879.
17. Yan GZ, Ziff EB, (1997) Nerve growth factor induces transcription of the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor. Journal of Neuroscience 17: 6122.
18. Krainc D, Bai G, Okamoto S, Carles M, Kusiak JW, et al. (1998) Synergistic activation of the N-methyl-D-aspartate receptor subunit 1 promoter by myocyte enhancer factor 2C and Sp1. Journal of Biological Chemistry 273: 26218.
19. Black AR, Jensen D, Lin SY, Azizkhan JC, (1999) Growth/cell cycle regulation of Sp1 phosphorylation. Journal of Biological Chemistry 274: 1207.
20. Ryu H, Lee J, Zaman K, Kubilis J, Ferrante RJ, et al. (2003) Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. Journal of Neuroscience 23: 3597.
21. Dunah AW, Jeong H, Griffin A, Kim YM, Standaert DG, et al. (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296: 2238.
22. Dittmer J, (2003) The biology of the Ets1 proto-oncogene. Mol Cancer 2: 29.
23. Verger A, Duterque Coquillaud M, (2002) When Ets transcription factors meet their partners. Bioessays 24: 362-370.
24. Li R, Pei H, Watson DK, (2000) Regulation of Ets function by protein-protein interactions. Oncogene 19: 6514.
25. Kumar P, Garg R, Bolden G, Pandey KN, (2010) Interactive roles of Ets-1, Sp1, and acetylated histones in the retinoic acid-dependent activation of guanylyl cyclase/atrial natriuretic peptide receptor-A gene transcription. J Biol Chem.
26. Tapias A, (2008) Regulation of Sp1 by cell cycle related proteins. Cell cycle (Georgetown, Tex.) 7: 2856.
27. Lin S, Saxena NK, Ding X, Stein LL, Anania FA, (2006) Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism. Molecular Endocrinology 20: 3376.
28. Loeffler S, Fayard B, Weis J, Weissenberger J, (2005) Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int J Cancer 115: 202-213.
29. Kiryu-Seo S, Kato R, Ogawa T, Nakagomi S, Nagata K, et al. (2008) Neuronal injury-inducible gene is synergistically regulated by ATF3, c-Jun, and STAT3 through the interaction with Sp1 in damaged neurons. Journal of Biological Chemistry 283: 6988.
30. Yu H, Pardoll D, Jove R, (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nature Reviews Cancer 9: 798-809.
31. Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, et al. (2009) Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer. Annals of the New York Academy of Sciences 1171: 59-76.
32. Jones-Rhoades MW, Bartel DP, Bartel B, (2006) MicroRNAs and their regulatory roles in plants. Plant Biology 57: 19.
33. Nielsen CB, Shomron N, Sandberg R, Hornstein E, Kitzman J, et al. (2007) Determinants of targeting by endogenous and exogenous microRNAs and siRNAs. Rna 13: 1894.
34. Su H, Trombly MI, Chen J, Wang X, (2009) Essential and overlapping functions for mammalian Argonautes in microRNA silencing. Genes & development 23: 304.
35. Filipowicz W, Bhattacharyya SN, Sonenberg N, (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Reviews Genetics 9: 102-114.
36. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
37. Pillai RS, Bhattacharyya SN, Artus CG, Zoller T, Cougot N, et al. (2005) Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 309: 1573.
38. Behm-Ansmant I, Rehwinkel J, Doerks T, Stark A, Bork P, et al. (2006) mRNA degradation by miRNAs and GW182 requires both CCR4: NOT deadenylase and DCP1: DCP2 decapping complexes. Genes & development 20: 1885.
39. Sen GL, Blau HM, (2005) Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nature cell biology 7: 633-636.
40. Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R, (2005) MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nature cell biology 7: 719.
41. Jakymiw A, Lian S, Eystathioy T, Li S, Satoh M, et al. (2005) Disruption of GW bodies impairs mammalian RNA interference. Nature cell biology 7: 1167.
42. Meister G, Landthaler M, Peters L, Chen PY, Urlaub H, et al. (2005) Identification of novel argonaute-associated proteins. Current biology 15: 2149-2155.
43. Kim VN, (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nature reviews. Molecular cell biology 6: 376.
44. Tomari Y, Zamore PD, (2005) Perspective: machines for RNAi. Genes & development 19: 517.
45. Zamore PD, Haley B, (2005) Ribo-gnome: the big world of small RNAs. Science 309: 1519.
46. Filipowicz W, (2005) RNAi: the nuts and bolts of the RISC machine. Cell 122: 17-20.
47. Pillai RS, Bhattacharyya SN, Filipowicz W, (2007) Repression of protein synthesis by miRNAs: how many mechanisms? Trends in cell biology 17: 118-126.
48. Marinescu VD, Kohane IS, Riva A, (2005) The MAPPER database: a multi-genome catalog of putative transcription factor binding sites. Nucleic acids research 33: D91.
49. Petersohn D, Thiel G, (1996) Role of zinc-finger proteins Sp1 and zif268/egr-1 in transcriptional regulation of the human synaptobrevin II gene. European Journal of Biochemistry 239: 827-834.
50. Kim KR, Yoshizaki T, Miyamori H, Hasegawa K, Horikawa T, et al. (2000) Transformation of Madin-Darby canine kidney(MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP 1) induces expression of Ets 1 and invasive growth. Oncogene(Basingstoke) 19: 1764-1771.
51. Dunah AW, Jeong H, Griffin A, Kim YM, Standaert DG, et al. (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296: 2238.
52. Hung JJ, Wang YT, Chang WC, (2006) Sp1 deacetylation induced by phorbol ester recruits p300 to activate 12 (S)-lipoxygenase gene transcription. Molecular and Cellular Biology 26: 1770.
53. Huang W, Zhao S, Ammanamanchi S, Brattain M, Venkatasubbarao K, et al. (2005) Trichostatin A induces transforming growth factor β type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1•NF-Y complex. Journal of Biological Chemistry 280: 10047-10054.
54. Yoshida M, Kijima M, Akita M, Beppu T, (1990) Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. Journal of Biological Chemistry 265: 17174-17179.
55. Sternson SM, Wong JC, Grozinger CM, Schreiber SL, (2001) Synthesis of 7200 small molecules based on a substructural analysis of the histone deacetylase inhibitors trichostatin and trapoxin. Org Lett 3: 4239-4242.
56. Emiliani S, Fischle W, Van Lint C, Al-Abed Y, Verdin E, (1998) Characterization of a human RPD3 ortholog, HDAC3. Proceedings of the National Academy of Sciences of the United States of America 95: 2795.
57. Persengiev SP, Zhu X, Green MR, (2004) Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10: 12.
58. Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams B, (2003) Activation of the interferon system by short-interfering RNAs. Nature Cell Biology 5: 834-839.
59. Kim DH, Longo M, Han Y, Lundberg P, Cantin E, et al. (2004) Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nature biotechnology 22: 321-325.
60. Kariko K, Bhuyan P, Capodici J, Weissman D, (2004) Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. The Journal of Immunology 172: 6545.
61. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, et al. (2003) Expression profiling reveals off-target gene regulation by RNAi. Nature Biotechnology 21: 635-637.
62. Caldenhoven E, Van Dijk TB, Solari R, Armstrong J, Raaijmakers JA, et al. (1996) STAT 3 β, a splice variant of transcription factor STAT 3, is a dominant negative regulator of transcription. Journal of Biological Chemistry 271: 13221-13227.
63. Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, et al. (1996) A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. The EMBO journal 15: 3651.
64. Liu L, McBride KM, Reich NC, (2005) STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-α3. Proceedings of the National Academy of Sciences of the United States of America 102: 8150.
65. Dominski Z, Yang X, Kaygun H, Dadlez M, Marzluff WF, (2003) A 3′ exonuclease that specifically interacts with the 3′ end of histone mRNA. Molecular cell 12: 295-305.
66. Torigoe T, Izumi H, Wakasugi T, Niina I, Igarashi T, et al. (2005) DNA topoisomerase II poison TAS-103 transactivates GC-box-dependent transcription via acetylation of Sp1. Journal of Biological Chemistry 280: 1179.
67. Suzuki T, Kimura A, Nagai R, Horikoshi M, (2000) Regulation of interaction of the acetyltransferase region of p300 and the DNA-binding domain of Sp1 on and through DNA binding. Genes to Cells 5: 29.
68. Schnur N, Seuter S, Katryniok C, Radmark O, Steinhilber D, (2007) The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes. Biochim Biophys Acta 1771: 1271-1282.
69. Shimizu R, Kikuchi J, Wada T, Ozawa K, Kano Y, et al. (2010) HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells. Leukemia 24: 1760-1768.
70. Chen BK, Chang WC, (2000) Functional interaction between c-Jun and promoter factor Sp1 in epidermal growth factor-induced gene expression of human 12 (S)-lipoxygenase. Proceedings of the National Academy of Sciences 97: 10406.
71. Kardassis D, Papakosta P, Pardali K, Moustakas A, (1999) c-Jun transactivates the promoter of the human p21 WAF1/Cip1 gene by acting as a superactivator of the ubiquitous transcription factor Sp1. Journal of Biological Chemistry 274: 29572.
72. Ray S, Lee C, Hou T, Boldogh I, Brasier AR, (2008) Requirement of histone deacetylase 1(HDAC 1) in signal transducer and activator of transcription 3(STAT 3) nucleocytoplasmic distribution. Nucleic Acids Research 36: 4510.
73. Pushparaj PN, H Ng SC, Melendez AJ, (2008) Refining siRNA in vivo transfection: Silencing SPHK1reveals its key role in C5a-induced inflammation in vivo. International Journal of Biochemistry and Cell Biology 40: 1817-1825.
74. Qian ZK, Xuan BQ, Min TS, Xu JF, Li L, et al. (2005) Cost-effective method of siRNA preparation and its application to inhibit hepatitis B virus replication in HepG2 cells. World J Gastroenterol 11: 1297-1302.
75. Hong J, Zhao Y, Huang W, (2006) Blocking c-myc and stat3 by E. coli expressed and enzyme digested siRNA in mouse melanoma. Biochemical and Biophysical Research Communications 348: 600-605.
76. Xuan B, Qian Z, Tan C, Min T, Shen S, et al. (2005) esiRNAs purified with chromatography suppress homologous gene expression with high efficiency and specificity. Molecular biotechnology 31: 203-209.
77. Santiago FS, Khachigian LM, (2004) Ets-1 stimulates platelet-derived growth factor A-chain gene transcription and vascular smooth muscle cell growth via cooperative interactions with Sp1. Circulation research 95: 479.
78. Sliva K, Schnierle BS, (2006) Stable integration of a functional shRNA expression cassette into the murine leukemia virus genome. Virology 351: 218-225.
79. Fujimoto E, Sato H, Shirai S, Nagashima Y, Fukumoto K, et al. (2005) Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line. Oncogene 24: 3684-3690.
80. Leslie K, Lang C, Devgan G, Azare J, Berishaj M, et al. (2006) Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Cancer research 66: 2544.
81. H Lzel M, Orban M, Hochstatter J, Rohrmoser M, Harasim T, et al. (2010) Defects in 18 S or 28 S rRNA processing activate the p53 pathway. Journal of Biological Chemistry 285: 6364.
82. Gess B, Halfter H, Kleffner I, Monje P, Athauda G, et al. (2008) Inhibition of N-cadherin and β-catenin function reduces axon-induced Schwann cell proliferation. Journal of neuroscience research 86: 797-812.
83. Chandrasekar B, Mummidi S, Mahimainathan L, Patel DN, Bailey SR, et al. (2006) Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-κB-and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. Journal of Biological Chemistry 281: 15099.
84. Zhang J, Smolen GA, Haber DA, (2008) Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway. Cancer research 68: 2789.
85. Zhang X, Shan P, Jiang D, Noble PW, Abraham NG, et al. (2004) Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. Journal of Biological Chemistry 279: 10677.
86. Lee C, Dhillon J, Wang M, Gao Y, Hu K, et al. (2008) Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice. Cancer Research 68: 8661.
87. Tong L, Chen Z, De Paiva CS, Beuerman R, Li DQ, et al. (2006) Transglutaminase participates in UVB-induced cell death pathways in human corneal epithelial cells. Investigative ophthalmology & visual science 47: 4295.
88. Yang SL, Cao Q, Zhou KC, Feng YJ, Wang YZ, (2009) Transient receptor potential channel C3 contributes to the progression of human ovarian cancer. Oncogene 28: 1320-1328.
89. Rozen S, Skaletsky H, (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386.
90. Berger J, Hauber J, Hauber R, Geiger R, Cullen BR, (1988) Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66: 1.
91. Dyer RB, Herzog NK, (1995) Immunodepletion EMSA: a novel method to identify proteins in a protein-DNA complex. Nucleic acids research 23: 3345.
92. Yoshida T, Shiraishi T, Nakata S, Horinaka M, Wakada M, et al. (2005) Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous protein. Cancer research 65: 5662.
93. Diamond DA, Parsian A, Hunt CR, Lofgren S, Spitz DR, et al. (1999) Redox factor-1 (Ref-1) mediates the activation of AP-1 in HeLa and NIH 3T3 cells in response to heat shock. Journal of Biological Chemistry 274: 16959.
94. Greenwel P, Inagaki Y, Hu W, Walsh M, Ramirez F, (1997) Sp1 is required for the early response of α2 (I) collagen to transforming growth factor-β1. Journal of Biological Chemistry 272: 19738.
95. Campillos M, Lamas JR, García MA, Bullido MJ, Valdivieso F, et al. (2003) Specific interaction of heterogeneous nuclear ribonucleoprotein A1 with the-219T allelic form modulates APOE promoter activity. Nucleic acids research 31: 3063.